carvedilol and leptin

carvedilol has been researched along with leptin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Androne, AS; Hryniewicz, K; Hudaihed, A; Katz, SD	1
Gobec, L; Kovacić, D; Lainscak, M; Marinsek, M; Podbregar, M	1
Baker, S; Dang, TB; Doan, KV; Kim, KW; Le Tran, T; Nguyen, LV; Nguyen, PH; Nguyen, T; Nguyen, TH; Pham, TVH; Ta, QV; Yang, DJ	1

Trials

1 trial(s) available for carvedilol and leptin

Article	Year
Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure. Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Blood Glucose; Body Weight; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Homeostasis; Humans; Insulin; Insulin Resistance; Leptin; Male; Middle Aged; Propanolamines; Resistin	2008

Article

Year

Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.

Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:1

Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Blood Glucose; Body Weight; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Homeostasis; Humans; Insulin; Insulin Resistance; Leptin; Male; Middle Aged; Propanolamines; Resistin

2008

Other Studies

2 other study(ies) available for carvedilol and leptin

Article	Year
Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. Journal of cardiac failure, 2003, Volume: 9, Issue:6 Topics: Adrenergic beta-Antagonists; Biomarkers; Blood Pressure; Body Weight; Cachexia; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Heart Rate; Humans; Insulin; Leptin; Male; Metoprolol; Middle Aged; Norepinephrine; Propanolamines; Prospective Studies; Severity of Illness Index; Stroke Volume; Treatment Outcome	2003
Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice. PloS one, 2019, Volume: 14, Issue:11 Topics: Adipose Tissue, White; Administration, Oral; Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Carvedilol; Diet, High-Fat; Disease Models, Animal; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Leptin; Liver; Male; Mice; Norepinephrine; Obesity; Signal Transduction	2019

Article

Year

Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure.

Journal of cardiac failure, 2003, Volume: 9, Issue:6

Topics: Adrenergic beta-Antagonists; Biomarkers; Blood Pressure; Body Weight; Cachexia; Carbazoles; Carvedilol; Chronic Disease; Female; Heart Failure; Heart Rate; Humans; Insulin; Leptin; Male; Metoprolol; Middle Aged; Norepinephrine; Propanolamines; Prospective Studies; Severity of Illness Index; Stroke Volume; Treatment Outcome

2003

Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice.

PloS one, 2019, Volume: 14, Issue:11

Topics: Adipose Tissue, White; Administration, Oral; Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Carvedilol; Diet, High-Fat; Disease Models, Animal; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Leptin; Liver; Male; Mice; Norepinephrine; Obesity; Signal Transduction

2019